Xylem Inc.
XYL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $36 | $31 | $29 | $28 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $37 | $32 | $30 | $29 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -1.4% | 11.2% | -8.3% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 38.9% | 38.8% | 37.1% | 38% |
| EBITDA | $0 | $0 | $0 | $1 |
| % Margin | 19.6% | 19.7% | 17.9% | 23.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 10% | 9.8% | 8.2% | 14.5% |
| EPS Diluted | 0.93 | 0.93 | 0.69 | 1.34 |
| % Growth | 0% | 34.8% | -48.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |